Online Only Articles

Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis

National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
National Amyloidosis Centre, University College London (Royal Free Campus), Rowland Hill Street, London, UK
Vol. 103 No. 4 (2018): April, 2018 https://doi.org/10.3324/haematol.2017.178095